# EDGAR Filing Document

**Accession Number:** 0001308547
**File Stem:** 0000950170-25-085748
**Filing Date:** 2025-6
**Character Count:** 7651
**Document Hash:** f40bddaf8324f4af863031b6030a45ff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-085748.hdr.sgml**: 20250612

**ACCESSION NUMBER**: 0000950170-25-085748

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250610

**FILED AS OF DATE**: 20250612

**DATE AS OF CHANGE**: 20250612

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** YEAMAN KEVIN J
- **CENTRAL INDEX KEY:** 0001200469

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32431
- **FILM NUMBER:** 251044524

**MAIL ADDRESS:**
- **STREET 1:** C/O DOLBY LABORATORIES, INC.
- **STREET 2:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Dolby Laboratories, Inc.
- **CENTRAL INDEX KEY:** 0001308547
- **STANDARD INDUSTRIAL CLASSIFICATION:** PATENT OWNERS & LESSORS [6794]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 900199783
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0927

**BUSINESS ADDRESS:**
- **STREET 1:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103
- **BUSINESS PHONE:** 415 558 0200

**MAIL ADDRESS:**
- **STREET 1:** 1275 MARKET STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94103

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>YEAMAN KEVIN J<br><sub>(Last) (First) (Middle)</sub><br>C/O DOLBY LABORATORIES, INC.<br>1275 MARKET STREET<br><sub>(Street)</sub><br>SAN FRANCISCO, CA 94103<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-10 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President and CEO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Dolby Laboratories, Inc. [ DLB ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2025-06-10 |  | M |  | 25000 | A | $45.5 | 139725 | I | By a trust<sup>(1)</sup> |
| Class A Common Stock | 2025-06-10 |  | M |  | 8683 | A | $64.6 | 148408 | I | By a trust<sup>(1)</sup> |
| Class A Common Stock | 2025-06-10 |  | S |  | 33504 | D | 76.223<sup>(2)</sup> | 114904 | I | By a trust<sup>(1)</sup> |
| Class A Common Stock | 2025-06-10 |  | S |  | 179 | D | $76.57 | 114725 | I | By a trust<sup>(1)</sup> |
| Class A Common Stock |  |  |  |  |  |  |  | 127735<sup>(3)</sup> | D |  |
| Class A Common Stock |  |  |  |  |  |  |  | 2.5592 | I | By a son |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (Right to Buy) | $45.5 | 2025-06-10 |  | M |  |  | 25000 | <sup>(4)</sup> | 2026-12-15 | Class A Common Stock | 25000 | $0 | 160615 | I | By a trust<sup>(1)</sup> |
| Employee Stock Option (Right to Buy) | $64.6 | 2025-06-10 |  | M |  |  | 8683 | <sup>(5)</sup> | 2025-12-17 | Class A Common Stock | 8683 | $0 | 52817 | I | By a trust<sup>(1)</sup> |

---

### Footnotes:

(1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009

(2) The shares were sold in multiple transactions at prices ranging from $75.555 to $76.50, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

(3) Shares held following the reported transactions include 127,735 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

(4) This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.

(5) This performance-based stock option award was granted for a total of 82,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 61,500 shares.

**Signature:** /s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman  
**Date:** 2025-06-12

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**